This study investigated if saffron supplementation (SS) improves rheumatoid arthritis (RA) symptoms. They found that SS reduced disease activity (DA) in patients with RA.

This study investigated the effect of vegetable and seafood intake in patients with rheumatoid arthritis (RA). 

They found that high vegetable and seafood intake may be associated with lower disease activity (LDA).

This study investigated if garlic supplementation improves rheumatoid arthritis (RA) symptoms and inflammation. 

They found that garlic supplements improved pain and quality of life (QoL) in these patients. 

This study investigated the long-term safety and effectiveness of peficitinib (Smyraf) in rheumatoid arthritis (RA). They found that this treatment lowered disease activity (DA) and was well tolerated. 

This study examined if there was a difference in patients with breast cancer first treated with chemotherapy that had a wide or narrow margin of healthy tissue removed during surgery. The results showed that the outcomes were similar regardless of how much healthy tissue was removed.

This study examined if acupuncture is an effective treatment for patients with nerve damage caused by chemotherapy for breast cancer. The results showed that patients had improved sensory and muscle symptoms, less pain, and improved quality of life following acupuncture treatment.

This study investigated the effectiveness of Janus kinase (JAK) inhibitors in rheumatoid arthritis (RA). They found that JAK inhibitors were more effective than conventional RA drugs. 

This study evaluated whether melatonin could improve the side effects of chemotherapy for women with breast cancer. It found that melatonin improved sleep, depression symptoms, and clear thinking during chemotherapy.

This study investigated if reducing the doses (tapering) of biologic drugs maintains effectiveness in patients with rheumatoid arthritis (RA). 

They found that drug tapering maintained low disease activity (LDA) and remission while reducing side effects and costs.

This study examined the effectiveness of three commonly used therapies to prevent bone loss in patients with hormone-positive breast cancer (BC). The results showed that the therapies prevented bone loss and fractures but to different degrees.